Toripalimab in Combined With Cetuximab,Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC
Phase 2 Unknown
33 enrolled
Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
Phase 2 Unknown
131 enrolled
Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer
Phase 2 Unknown
120 enrolled
Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma
Phase 2 Unknown
215 enrolled
Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer
Phase 1 Unknown
20 enrolled
Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial
Phase 3 Unknown
160 enrolled
Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 3 Unknown
562 enrolled
Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients
Phase 2 Unknown
90 enrolled
Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN)
Phase 3 Unknown
334 enrolled
Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 2 Unknown
37 enrolled
MEDINDUCTION
Phase 1 Unknown
36 enrolled
A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Phase 2 Unknown
328 enrolled
Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma
Phase 3 Unknown
54 enrolled
Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer
Phase 3 Unknown
120 enrolled
The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Unknown
120 enrolled
Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 3 Unknown
476 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
Phase 2 Unknown
Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
Phase 3 Unknown
200 enrolled
Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
Phase 3 Unknown
240 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
Phase 1 Unknown
Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Phase NA Unknown
798 enrolled
Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 3 Unknown
506 enrolled
Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
Phase 2 Unknown
90 enrolled
ESNCCT
Phase 3 Unknown
400 enrolled
Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)
Phase NA Unknown
340 enrolled
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
Phase 2 Unknown
TPF for NPC
Phase 2 Unknown
100 enrolled
Phase â…¡ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage â…£AB Nasopharyngeal Carcinoma
Phase 2 Unknown
64 enrolled
Phase â…¡ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage â…¢ Nasopharyngeal Carcinoma
Phase 2 Unknown
52 enrolled